C
CTOR
Citius Oncology, Inc.
0.6422
-0.0217-3.27%After Hours: 0.6400 -0.0022 -0.34%18:01 04/08 EDT
OPEN/PREV CLOSE0.6294/0.6422
TODAY RANGE0.6160-0.6700
VOL6.19K
MARKET CAP58.26M
52 WEEK RANGE0.4912-6.19
AVG VOL (3M)270.57K
% TURNOVER0.11%
TURNOVER0
P/E (TTM)-2.1283
% RANGE8.39%
EPS(TTM)-0.3101
P/E(FORWARD)-3.4737
P/B0.9580
BVPS0.6889
DIVIDEND--
P/S--
BETA--
DIV YIELD0.00%
FREE FLOAT MKT CAP12.80M
SHARES OUTSTANDING88.28M
NEXT EARNINGS05/12-05/18
FREE FLOAT19.40M
LOT SIZE1
EX-DATE--
News
Press Releases
Financial Reports
Profile
TipRanks·04/01 03:32
Citius Oncology highlights early LYMPHIR commercial traction, expansion
TipRanks·03/31 13:40
Citius Oncology provides commercial update on lymphir launch
Benzinga·03/18 12:05
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
TipRanks·03/10 13:28
Citius Oncology Reports Positive Phase 1 LYMPHIR Combination Data
TipRanks·03/10 12:58
Citius Oncology’s Lymphir shows positive results in gynecologic cancers
TipRanks·03/04 14:48
Citius Oncology Announces Positive Phase 1 LYMPHIR Data
TipRanks·03/04 14:21
Citius Oncology reports results from Phase 1 trial evaluating LYMPHIR
Benzinga·02/13 13:24
Earnings Breakdown: Citius Oncology Q1
Benzinga·02/13 13:12
Citius Oncology Q1 Earnings Summary & Key Takeaways
Same Industry
Name/Symbol
Change%
Price